Sonova Holding (OTCMKTS:SONVY) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Sonova Holding has a consensus analyst rating of “Moderate Buy” from eight covering firms, with one sell, four hold, one buy, and two strong buy ratings.
• Recent analyst changes were mixed: Zacks upgraded Sonova from strong sell to hold, BNP Paribas Exane lifted it from strong sell to strong buy, while Jefferies downgraded it from hold to moderate sell.
• The stock opened at $45.99, trading near its 12-month low of $42.26 and below its 12-month high of $68.76; Sonova remains a hearing care company known for brands like Phonak and Unitron.

Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, one has issued a buy recommendation and two have issued a strong buy recommendation on the company.

Several research firms recently issued reports on SONVY. Zacks Research raised Sonova from a "strong sell" rating to a "hold" rating in a research report on Monday, February 9th. BNP Paribas Exane raised Sonova from a "strong sell" rating to a "strong-buy" rating in a research report on Tuesday, March 10th. Finally, Jefferies Financial Group cut Sonova from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, March 18th.

Sonova Price Performance

SONVY stock opened at $45.99 on Friday. Sonova has a 12-month low of $42.26 and a 12-month high of $68.76. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock's 50 day simple moving average is $46.75 and its 200 day simple moving average is $50.55.

About Sonova

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.